Moneycontrol PRO

Followers

5
5
4
4
.
7
7
2
2
4
4
-18.50 (-4.15%)

As on 19 Sep, 2025 | 15:56

Open Trading A/c
Day Range
425.20
450.00
LH
52 Week Range
259.70
581.90
LH
Volume
* i
Bid / Ask
243,094.00
427.45 / 562.00

Panacea Biotec Announcements

Please note that the Company has sent reminder letters on September 19, 2025, to the shareholders holding shares in physical mode, requesting them to furnish...

19 Sep, 2025 | 04:41pm • Source: BSE

Please find enclosed newspaper copies regarding advertisement of Notice of 41st Annual General Meeting, Cut-off Date and Remote e-voting information, published on September 09, 2025.

09 Sep, 2025 | 03:19pm • Source: BSE

Please find attached demat status report for the month of August 2025.

08 Sep, 2025 | 05:56pm • Source: BSE

We would like to inform you that pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the enclosed letter is...

08 Sep, 2025 | 05:43pm • Source: BSE

Please find attached Business Responsibility and Sustainability Report for financial year 2024-25

08 Sep, 2025 | 04:37pm • Source: BSE

Please find attached Annual Report for financial year 2024-25

08 Sep, 2025 | 04:34pm • Source: BSE

Please find enclosed AGM Notice and Annual Report for FY 2024-25, which is being sent to the Members through electronic mode.

08 Sep, 2025 | 04:20pm • Source: BSE

Please find enclosed newspaper copies of the public notice, requesting shareholders to register their email addresses with the Company in connection with ensuing AGM of...

30 Aug, 2025 | 05:10pm • Source: BSE

Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results published on August 15, 2025

16 Aug, 2025 | 12:37pm • Source: BSE

Please find attached details of shares dematerialised during July 2025.

07 Aug, 2025 | 04:46pm • Source: BSE

Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and...

04 Aug, 2025 | 06:08pm • Source: BSE

We would like to inform you that Mr. Mohammed Shafiqur Rahman has ceased to be the Senior Management Personnel of the Company with effect from...

31 Jul, 2025 | 08:18pm • Source: BSE

We are pleased to inform that the Company has received on July 29, 2025, the requisite approval from BSE and NSE for reclassification from "Promoter...

29 Jul, 2025 | 05:43pm • Source: BSE

In connection with our earlier letter dated August 20, 2024, please find attached Demand Order dated 10.07.2025 from the office of the Assistant Commissioner of...

11 Jul, 2025 | 04:52pm • Source: BSE

We are pleased to inform you that the parties have executed a Settlement Agreement on July 09, 2025, recording full and final settlement of the...

09 Jul, 2025 | 03:19pm • Source: BSE

We would like to inform you that no share has been dematerialised during the month of June, 2025. A copy of the certificate from the...

07 Jul, 2025 | 04:44pm • Source: BSE

We are enclosing a certificate dated July 02, 2025, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance...

07 Jul, 2025 | 04:40pm • Source: BSE

We would like to inform that the trading window of the Company shall remain closed for all the Designated Persons (including their immediate relatives) of...

26 Jun, 2025 | 05:18pm • Source: BSE

We are enclosing herewith the details of shares dematerialised during the month of May, 2025. A copy of the certificate obtained from RTA in this...

06 Jun, 2025 | 03:46pm • Source: BSE

Panacea Biotec Limited has informed the Exchange regarding a press release dated Jun 03, 2025, titled "Press Release - Inclusion of EmulsiPan adjuvant in the...

03 Jun, 2025 | 11:25am • Source: NSE